Author
Listed:
- Masanori Sano
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
- Tohru Minamino
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
- Haruhiro Toko
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
- Hideyuki Miyauchi
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
- Masayuki Orimo
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
- Yingjie Qin
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
- Hiroshi Akazawa
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
- Kaoru Tateno
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
- Yosuke Kayama
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
- Mutsuo Harada
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
- Ippei Shimizu
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
- Takayuki Asahara
(Stem Cell Translational Research, Kobe Institute of Biomedical Research and Innovation/RIKEN Center for Developmental Biology, 2-2 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan)
- Hirofumi Hamada
(Sapporo Medical University, S1 W17, Chuo-ku, Sapporo 060-8556, Japan)
- Shuhei Tomita
(Institute for Genome Research, University of Tokushima, 3-18-15 Kuramoto, Tokushima 770-8503, Japan)
- Jeffrey D. Molkentin
(Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio 45229-3039, USA)
- Yunzeng Zou
(Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, 180 Feng Lin Road, Shanghai 200032, China)
- Issei Komuro
(Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan)
Abstract
Heading off heart failure Cardiac enlargement, or hypertrophy, is a physiological response to increased workload and helps to maintain cardiac function. If the condition is prolonged, however, it can develop into heart failure. New insight into how that transition occurs has been obtained in a study of a mouse model of cardiac hypertrophy. As the animal's heart enlarges, new blood vessels develop to support it. But after about two weeks, the tumour suppressor protein p53 accumulates in heart cells, angiogenesis is blocked and the mice suffer cardiac failure. Targeting this process by inhibiting p53 or by promoting angiogenesis may be a means of preventing the transition from cardiac hypertrophy to heart failure.
Suggested Citation
Masanori Sano & Tohru Minamino & Haruhiro Toko & Hideyuki Miyauchi & Masayuki Orimo & Yingjie Qin & Hiroshi Akazawa & Kaoru Tateno & Yosuke Kayama & Mutsuo Harada & Ippei Shimizu & Takayuki Asahara & , 2007.
"p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload,"
Nature, Nature, vol. 446(7134), pages 444-448, March.
Handle:
RePEc:nat:nature:v:446:y:2007:i:7134:d:10.1038_nature05602
DOI: 10.1038/nature05602
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Muhammad Imran & Muhammad Nadeem & Muhammad Asif Khan & Sheraz Ahmed & Ali Imran & Rai Muhammad Amir & Muhammad Umair Arshad & Syed Amir Gilani & Farhan Saeed & Abdur Rauf & Zaffar Mehmood & Shaista K, 2017.
"Curcumin and its allied analogues: epigenetic and health perspectives - a review,"
Czech Journal of Food Sciences, Czech Academy of Agricultural Sciences, vol. 35(4), pages 285-310.
- Fabian Peisker & Maurice Halder & James Nagai & Susanne Ziegler & Nadine Kaesler & Konrad Hoeft & Ronghui Li & Eric M. J. Bindels & Christoph Kuppe & Julia Moellmann & Michael Lehrke & Christian Stopp, 2022.
"Mapping the cardiac vascular niche in heart failure,"
Nature Communications, Nature, vol. 13(1), pages 1-20, December.
- Toshiyuki Ko & Seitaro Nomura & Shintaro Yamada & Kanna Fujita & Takanori Fujita & Masahiro Satoh & Chio Oka & Manami Katoh & Masamichi Ito & Mikako Katagiri & Tatsuro Sassa & Bo Zhang & Satoshi Hatsu, 2022.
"Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis,"
Nature Communications, Nature, vol. 13(1), pages 1-17, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:446:y:2007:i:7134:d:10.1038_nature05602. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.